Global large Volume Infusion Pumps Market Size By Type (Fully automatic, Semi-automatic), By Application (Ambulatory surgical centers (ASCs), Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Large Volume Infusion Pumps Market was valued at USD 3.4 billion in 2023 and is projected to reach USD 6.1 billion by 2031, expanding at a CAGR of 7.5% during the forecast period (2023–2031). Large volume infusion pumps (LVIPs) are widely used in clinical settings to deliver fluids, such as nutrients and medications, into a patient's body in large amounts. The increasing demand for advanced drug delivery systems, a rising prevalence of chronic diseases like cancer and diabetes, and growing hospital admissions are driving market growth. Additionally, the rising use of infusion therapy in home care settings and continuous technological innovations are further propelling market expansion.

Drivers:

1. Increasing Hospitalization Rates for Chronic Diseases

The global rise in chronic illnesses, especially among aging populations, is fueling the demand for infusion therapies. LVIPs are vital for delivering life-saving medications in inpatient and outpatient environments.

2. Advancements in Infusion Pump Technology

The introduction of smart infusion systems with safety features like dose error reduction systems (DERS), wireless connectivity, and EHR integration is boosting their adoption across healthcare facilities.

3. Expansion of Home Healthcare Services

A shift toward patient-centric care and cost containment is increasing the adoption of infusion pumps for home-based therapies. LVIPs that offer portability and ease of use are gaining significant traction.

Restraints:

1. High Cost of Devices and Maintenance

The initial capital investment and recurring maintenance expenses for large volume infusion pumps, especially those with advanced features, may limit their adoption in under-resourced healthcare settings.

2. Risk of Device Errors and Recalls

Device malfunctions and programming errors, though rare, can lead to serious consequences. Regulatory recalls due to safety concerns could hinder market trust and adoption.

Opportunity:

1. Integration with Healthcare IT Systems

The increasing push toward healthcare digitization offers an opportunity for LVIPs integrated with electronic health records and remote monitoring tools, enabling personalized and data-driven care.

2. Growing Demand in Emerging Economies

Rising healthcare infrastructure, increasing investments in medical technologies, and an expanding patient base in regions such as Asia-Pacific and Latin America offer untapped market potential.

Market by System Type Insights:

The Electromechanical Infusion Pump segment dominated the market in 2023. These systems are preferred due to their high accuracy and reliability in delivering continuous and controlled drug infusions. The segment continues to grow, driven by adoption in intensive care units and oncology departments. However, the Smart Infusion Pump segment is anticipated to register the fastest growth rate due to increasing demand for digital healthcare solutions with enhanced safety features.

Market by End-use Insights:

In 2023, the Hospitals & Clinics segment emerged as the leading end-use category, accounting for over 50% of the market share. These facilities rely heavily on LVIPs for fluid therapy, chemotherapy, and nutrition support. The Homecare Settings segment is projected to witness the highest growth, fueled by increased patient preference for at-home treatment and the miniaturization of pump devices.

Market by Regional Insights:

North America held the largest share of the Global Large Volume Infusion Pumps Market in 2023, driven by well-established healthcare infrastructure, high adoption of advanced medical devices, and strong presence of market leaders. Asia-Pacific is expected to exhibit the highest CAGR through 2031 due to improving healthcare systems, a large patient pool, and growing awareness about infusion therapies.

Competitive Scenario:

Major players in the global large volume infusion pumps market include Becton, Dickinson and Company (BD), Baxter International Inc., ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi, Smiths Medical, Terumo Corporation, Moog Inc., Nipro Corporation, and Micrel Medical Devices SA. Key strategies among these companies include new product launches, strategic partnerships, and acquisitions. For instance:

In 2023, BD launched a new generation of smart infusion systems with enhanced cybersecurity and analytics capabilities.

ICU Medical expanded its product portfolio in 2024 through the acquisition of a niche infusion technology firm.

Fresenius Kabi introduced a cloud-based infusion platform to support remote drug administration in homecare environments.

Scope of Work – Global Large Volume Infusion Pumps Market

Report Metric Details

Market Size (2023) USD 3.4 Billion

Projected Market Size (2031) USD 6.1 Billion

CAGR (2023–2031) 7.5%

Market Segments System Type (Electromechanical, Smart Pumps), End-use (Hospitals & Clinics, Homecare Settings)

Growth Drivers Rising chronic disease prevalence, healthcare automation, home infusion trends

Opportunities Emerging market adoption, smart pump integration with digital health tools

Key Market Developments:

May 2023: Baxter International unveiled its next-gen infusion system with advanced drug library features, aiming to reduce medication errors.

February 2024: Terumo Corporation introduced a compact LVIP designed specifically for pediatric and neonatal care units.

January 2025: B. Braun partnered with a major healthcare IT provider to integrate infusion pump data into centralized patient records.

FAQs:

1) What is the current market size of the Global Large Volume Infusion Pumps Market?

The market was valued at USD 3.4 billion in 2023.

2) What is the major growth driver of the Global Large Volume Infusion Pumps Market?

The rising prevalence of chronic diseases and increased demand for advanced drug delivery systems are the key growth drivers.

3) Which is the largest region during the forecast period in the Global Large Volume Infusion Pumps Market?

North America held the largest market share in 2023, while Asia-Pacific is projected to grow at the fastest rate.

4) Which segment accounted for the largest market share in the Global Large Volume Infusion Pumps Market?

The Hospitals & Clinics segment led the market in 2023 due to the high utilization of LVIPs in inpatient care.

5) Who are the key market players in the Global Large Volume Infusion Pumps Market?

Key players include Becton, Dickinson and Company (BD), Baxter International Inc., ICU Medical Inc., B. Braun Melsungen AG, and Fresenius Kabi.